Page 10 - மொழிபெயர் உயிர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Article content PARIS Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as it bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race, confirming a Reuters exclusive report. Sanofi said it would acquire all outstanding shares of Translate Bio for $38.00 per share in cash, representing a total equity value of about $3.2 billion for Translate Bio. We apologize, but this video has failed to load. Try refreshing your browser, or Sanofi to buy U.S. mRNA partner Translate Bio in $3.2 bln deal Back to video The boards of both companies have approved the deal, and the chief executive of Translate Bio and the U.S. company’s largest shareholder have backed the takeover offer, Sanofi and Translate Bio said in a joint statement.

New yorkUnited statesFrance generalSudip kar guptaMatthew lewisSonali paulJosephine masonPaul hudsonLewis krauskopfMatthias blamontAnkur banerjeeCaroline humerMorgan stanleyPostmedia network incTranslate bioSanofi chief executive paul